• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

摩洛哥与新冠病毒感染相关的儿童多系统炎症综合征(MIS-C)

Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With COVID-19 Infection in Morocco.

作者信息

Amenzoui Naima, Zouiter Siham, Nassid Meriem, Kholaiq Halima, Belkhou Ikbal, Benhsaien Ibtihal, Ailal Fatima, Adnane Fatima, Jouhadi Zineb, Bousfiha Ahmed Aziz

机构信息

Clinical Immunology and Infectious Pediatrics Department, Abderrahim Harouchi Mother and Childrens Hospital, Casablanca, Morocco.

Laboratory of Clinical Immunology, Inflammation and Allergy (LICIA), Hassan II University of Casablanca Faculty of Medicine and Pharmacy, Morocco.

出版信息

Glob Pediatr Health. 2024 Oct 28;11:2333794X241286772. doi: 10.1177/2333794X241286772. eCollection 2024.

DOI:10.1177/2333794X241286772
PMID:39493464
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11528631/
Abstract

. This study aims to describe the clinical and paraclinical characteristics of Multisysteminflammatory syndrome in children (MIS-C). . A retrospective study encompassing 52 children diagnosed with MIS-C according to the World Health Organization criteria, over a 3-year period at Abderrahim Harrouchi Hospital in Morocco. . The median age was 6 years (IQR: 1-14), with a sex ratio of 1.16 (28 boys and 24 girls). Clinical manifestations were predominantly characterized by fever in all cases (100%), respiratory and gastrointestinal symptoms in 30 cases (58%) and 23 cases (44%) respectively, and shock in 9 cases (17%). We noted a myocarditis in 6 cases (12%). The treatment comprised intravenous human Immunoglobulin combined with methylprednisolone in all patients (100%). . The characteristics of our MIS-C patients were similar to those in the literature, but more studies are needed to confirm these results.

摘要

本研究旨在描述儿童多系统炎症综合征(MIS-C)的临床和辅助检查特征。这是一项回顾性研究,在摩洛哥阿卜杜勒拉希姆·哈鲁奇医院对52名根据世界卫生组织标准诊断为MIS-C的儿童进行了为期3年的研究。中位年龄为6岁(四分位间距:1 - 14岁),性别比为1.16(28名男孩和24名女孩)。临床表现主要特征为所有病例均有发热(100%),30例(58%)有呼吸道症状,23例(44%)有胃肠道症状,9例(17%)有休克。我们注意到6例(12%)有心肌炎。所有患者(100%)的治疗包括静脉注射人免疫球蛋白联合甲泼尼龙。我们的MIS-C患者特征与文献中的相似,但需要更多研究来证实这些结果。

相似文献

1
Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With COVID-19 Infection in Morocco.摩洛哥与新冠病毒感染相关的儿童多系统炎症综合征(MIS-C)
Glob Pediatr Health. 2024 Oct 28;11:2333794X241286772. doi: 10.1177/2333794X241286772. eCollection 2024.
2
Multisystem inflammatory syndrome in children (MIS-C): A nationwide collaborative study in the Greek population.儿童多系统炎症综合征(MIS-C):希腊人群的全国性合作研究。
Eur J Pediatr. 2024 Apr;183(4):1693-1702. doi: 10.1007/s00431-023-05383-5. Epub 2024 Jan 12.
3
Multisystem Inflammatory Syndrome in Children (MIS-C) in a Low-income Country: What Treatment Should be Adopted in Case of a Lack of Immunoglobulin?儿童多系统炎症综合征(MIS-C)在低收入国家:如果缺乏免疫球蛋白,应采用何种治疗方法?
Rev Recent Clin Trials. 2024;19(2):150-157. doi: 10.2174/0115748871257131231204114803.
4
Multisystem inflammatory syndrome in children associated with COVID-19 in 101 cases from Turkey (Turk-MISC study).土耳其 101 例与 COVID-19 相关的儿童多系统炎症综合征(Turk-MISC 研究)。
J Paediatr Child Health. 2022 Jun;58(6):1069-1078. doi: 10.1111/jpc.15913. Epub 2022 Feb 24.
5
A retrospective comparative analysis of factors affecting the decision and outcome of initial intravenous immunoglobulin alone or intravenous immunoglobulin plus methylprednisolone use in children with the multisystem inflammatory syndrome.回顾性比较分析影响儿童多系统炎症综合征初始单独使用静脉注射免疫球蛋白或静脉注射免疫球蛋白联合甲泼尼龙治疗决策和结局的因素。
Pediatr Rheumatol Online J. 2022 Aug 20;20(1):69. doi: 10.1186/s12969-022-00726-2.
6
[Clinical analysis of 11 cases multisystem inflammatory syndrome associated with SARS-CoV-2 Omicron variant infection in children].11例儿童新型冠状病毒奥密克戎变异株感染相关多系统炎症综合征的临床分析
Zhonghua Er Ke Za Zhi. 2024 Jan 2;62(1):55-59. doi: 10.3760/cma.j.cn112140-20231021-00309.
7
Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Case Series Experience in a Tertiary Care Hospital of Southern Turkey.儿童多系统炎症综合征(MIS-C)与 COVID-19 相关:土耳其南部一家三级保健医院的病例系列经验。
J Trop Pediatr. 2021 May 17;67(2). doi: 10.1093/tropej/fmab050.
8
Comparison of the course of multisystem inflammatory syndrome in children during different pandemic waves.比较不同疫情波次期间儿童多系统炎症综合征的病程。
Eur J Pediatr. 2023 Apr;182(4):1647-1656. doi: 10.1007/s00431-022-04790-4. Epub 2023 Jan 31.
9
Cardiovascular injury and clinical features of multisystem inflammatory syndrome in children (MIS-C) related to Covid-19 in Vietnam.越南与 COVID-19 相关的儿童多系统炎症综合征 (MIS-C) 的心血管损伤和临床特征。
Pediatr Neonatol. 2022 Nov;63(6):569-574. doi: 10.1016/j.pedneo.2022.05.009. Epub 2022 Jul 8.
10
Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.静脉注射免疫球蛋白联合甲泼尼龙与单独使用免疫球蛋白治疗儿童多系统炎症综合征发热病程的关联。
JAMA. 2021 Mar 2;325(9):855-864. doi: 10.1001/jama.2021.0694.

本文引用的文献

1
Using HScore for Evaluation of Hemophagocytosis in Multisystem Inflammatory Syndrome Associated with COVID-19 in Children.使用HScore评估儿童新型冠状病毒肺炎相关多系统炎症综合征中的噬血细胞现象
Biomedicines. 2024 Jan 27;12(2):294. doi: 10.3390/biomedicines12020294.
2
Determination of Risk Factors for Severe Life-Threatening Course of Multisystem Inflammatory Syndrome Associated with COVID-19 in Children.儿童新型冠状病毒肺炎相关多系统炎症综合征严重危及生命病程的危险因素判定
Children (Basel). 2023 Aug 9;10(8):1366. doi: 10.3390/children10081366.
3
Multisystem inflammatory syndrome in children during the first two years of the COVID-19 pandemic in Luxembourg.卢森堡新冠疫情头两年期间儿童多系统炎症综合征
Front Pediatr. 2023 Apr 5;11:1141074. doi: 10.3389/fped.2023.1141074. eCollection 2023.
4
[Should we interfere with the interleukin-6 receptor during COVID-19: What do we know?].在新冠疫情期间我们是否应该干预白细胞介素-6受体:我们了解什么?
Rev Mal Respir. 2023 Jan;40(1):24-37. doi: 10.1016/j.rmr.2022.11.085. Epub 2022 Dec 9.
5
[Diagnosis of a pediatric inflammatory multisystemic syndrome associated with COVID-19].[与新型冠状病毒肺炎相关的儿童炎症性多系统综合征的诊断]
J Pediatr Pueric. 2023 Feb;36(1):1-7. doi: 10.1016/j.jpp.2022.11.001. Epub 2022 Nov 15.
6
The changing epidemiology of PIMS-TS across COVID-19 waves: prospective national surveillance, January 2021 to July 2022, England.2021年1月至2022年7月英国PIMS-TS在各波新冠疫情期间不断变化的流行病学情况:全国前瞻性监测
J Infect. 2022 Dec;85(6):702-769. doi: 10.1016/j.jinf.2022.10.017. Epub 2022 Oct 20.
7
Multisystemic Inflammatory Syndrome in Children, A Disease with Too Many Faces: A Single-Center Experience.儿童多系统炎症综合征:一种具有多种表现的疾病——单中心经验
J Clin Med. 2022 Sep 6;11(18):5256. doi: 10.3390/jcm11185256.
8
Acute kidney injury following multisystem inflammatory syndrome associated with SARS-CoV-2 infection in children: a systematic review and meta-analysis.儿童感染 SARS-CoV-2 相关多系统炎症综合征后的急性肾损伤:系统评价和荟萃分析。
Pediatr Nephrol. 2023 Feb;38(2):357-370. doi: 10.1007/s00467-022-05701-3. Epub 2022 Aug 9.
9
Multisystem Inflammatory Syndrome in Children (MIS-C).儿童多系统炎症综合征(MIS-C)。
Curr Allergy Asthma Rep. 2022 May;22(5):53-60. doi: 10.1007/s11882-022-01031-4. Epub 2022 Mar 22.
10
Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): a Brazilian cohort.儿童炎症性多系统综合征与 SARS-CoV-2 相关(PIMS-TS):巴西队列研究。
Adv Rheumatol. 2022 Feb 21;62(1):6. doi: 10.1186/s42358-022-00237-4.